Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Merck Team on HPV Dx, Rx in Developing World

NEW YORK (GenomeWeb News) – Qiagen and Merck will collaborate to provide HPV screening and vaccination to women in the developing world as part of the Clinton Global Initiative, the partners said today.

The goal is to integrate their offerings and provide them for free in order to combat cervical cancer.

Under the plan, Qiagen said that it will add to its existing one-million test donation program the screening of an additional 500,000 women in certain developing nations using its HPV tests, including the digene HC2 HPV DNA Test and a new HPV DNA test that is still under development for use specifically in the developing world, the company said. Merck will provide up to five million doses of its Gardasil vaccine for HPV Types 6, 11, 16, and 18.

Qiagen and Merck also plan to pursue other partners, public and private, to plan and implement cervical cancer programs to provide treatment, deliver vaccine doses, and to train healthcare workers. They also will work with cervical cancer experts to develop best practice models for cervical cancer reduction in low-income, high-disease areas.

"With broadened access to both vaccines and testing through this initiative, we hope to ensure that girls and women — regardless of where they live — will benefit from these advances in healthcare," Qiagen CEO Peer Schatz said in a statement. "Our complementary tools can demonstrate the unique impact that collaborations between pharmaceutical and diagnostic companies can have on global public health."

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.